Last reviewed · How we verify

NCT04228835

Does ICG Fluorescence Cholangiography Identify Critical View of Safety Earlier in Laparoscopic Cholecystectomy

Completed NA Last updated 14 January 2020
What this trial tests

NA trial testing Fluorescence Cholangiography in Cholelithiasis in 72 participants. Completed in 31 July 2019.

Timeline
1 March 2017
Primary endpoint
31 July 2019
31 July 2019

Quick facts

Lead sponsorUniversity of Malaya
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment72
Start date1 March 2017
Primary completion31 July 2019
Estimated completion31 July 2019
Sites1 location across Malaysia

Drugs / interventions tested

Conditions studied

Sponsor

University of Malaya

Who can join

18 and older, any sex, with Cholelithiasis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Achievement of critical view of safety (CVS) is recommended to reduce risk of hilar injury in laparoscopic cholecystectomy. Indocyanine green (ICG) fluorescence cholangiography, a novel technique of real time biliary visualization, is postulated to assist dissection during laparoscopic cholecystectomy (LC). However, its use in providing a faster and safer LC has yet to be established. The main objective of this study is to evaluate whether the use of ICG enhanced fluorescence cholangiography will help in earlier identification critical view of safety during LC.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Fluorescent cholangiography: An up-to-date overview twelve years after the first clinical application.
    Pesce A, Piccolo G, Lecchi F, Fabbri N, et al · · 2021 · cited 29× · PMID 34629815 · DOI 10.3748/wjg.v27.i36.5989
  2. Early identification of the critical view of safety in laparoscopic cholecystectomy using indocyanine green fluorescence cholangiography: A randomised controlled study.
    Koong JK, Ng GH, Ramayah K, Koh PS, et al · · 2021 · cited 20× · PMID 33223453 · DOI 10.1016/j.asjsur.2020.11.002

Verify or expand the search:

Other recruiting trials for Cholelithiasis

Currently open trials in the same condition.

Other University of Malaya trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04228835.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing